Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EXPONENT INCEXPO · Entity 4154 | VP Global Offices & Innovation | April 06, 2026 | April 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EXPONENT INC
Report date April 06, 2026 · Filed April 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Incentive Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.56 · Expires 2036-04-06 | Direct | 6,008 |
Reported balance
After 2026-04-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-04-06 · Grant · Acquired 6,008 · Balance 6,008 F2: Not applicable. F1: The stock option becomes exercisable in four equal annual installments. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.56 · Expires 2036-04-06 | Direct | 14,992 |
Reported balance
After 2026-04-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-04-06 · Grant · Acquired 14,992 · Balance 14,992 F2: Not applicable. F1: The stock option becomes exercisable in four equal annual installments. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option becomes exercisable in four equal annual installments.
F2: Not applicable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 06, 2026 Filed Apr 9, 2026 01:23 UTC | EXPONENT INC EXPO · Entity 4154 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 14,992 | Not disclosed Strike: $66.56 | Not disclosed |
DisclosureSEC source: 0000851520-26-000054 · edgardoc.xml · derivative · entry 2 Pye John · CIK 0001686997 · VP Global Offices & Innovation 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,992 Underlying: Common Stock · 14,992 shares Expires 2036-04-06 F2 · price: Not applicable. F1 · derivative.exercise_date: The stock option becomes exercisable in four equal annual installments. Read SEC document |
| April 06, 2026 Filed Apr 9, 2026 01:23 UTC | EXPONENT INC EXPO · Entity 4154 | GrantIncentive Stock Option (right to buy) · Derivative | 6,008 | Not disclosed Strike: $66.56 | Not disclosed |
DisclosureSEC source: 0000851520-26-000054 · edgardoc.xml · derivative · entry 1 Pye John · CIK 0001686997 · VP Global Offices & Innovation 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,008 Underlying: Common Stock · 6,008 shares Expires 2036-04-06 F2 · price: Not applicable. F1 · derivative.exercise_date: The stock option becomes exercisable in four equal annual installments. Read SEC document |
| March 13, 2026 Filed Mar 16, 2026 20:19 UTC | EXPONENT INC EXPO · Entity 4154 | GrantRestricted Stock Units · Derivative | 5,938 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-26-000047 · edgardoc.xml · derivative · entry 1 Pye John · CIK 0001686997 · VP Global Offices & Innovation 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,938 Underlying: Common Stock · 5,938 shares Expires 2030-03-13 F1 · derivative.exercise_price: 1-for-1. F2 · price: Not applicable. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 21:23 UTC | EXPONENT INC EXPO · Entity 4154 | Exercise / conversionRestricted Stock Units · Derivative | 5,934 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-26-000029 · edgardoc.xml · derivative · entry 3 Pye John · CIK 0001686997 · VP Global Offices & Innovation 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,934 shares Expires 2026-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the conversion of shares of vested Restricted Stock Units granted on March 11, 2022 into shares of Common Stock on a 1:1 basis. F1 · kind: Reflects the conversion of shares of vested Restricted Stock Units granted on March 11, 2022 into shares of Common Stock on a 1:1 basis. F2 · price: Not applicable. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 21:23 UTC | EXPONENT INC EXPO · Entity 4154 | Tax withholdingCommon Stock | 2,384 | $70.03 | $166,951.52 |
DisclosureSEC source: 0000851520-26-000029 · edgardoc.xml · nonDerivative · entry 2 Pye John · CIK 0001686997 · VP Global Offices & Innovation 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,131 F3 · kind: Reflects shares of common stock withheld by the Company to satify the tax withholding obligations of the Reporting Person. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 21:23 UTC | EXPONENT INC EXPO · Entity 4154 | Exercise / conversionCommon Stock | 5,934 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-26-000029 · edgardoc.xml · nonDerivative · entry 1 Pye John · CIK 0001686997 · VP Global Offices & Innovation 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,515 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects the conversion of shares of vested Restricted Stock Units granted on March 11, 2022 into shares of Common Stock on a 1:1 basis. F2 · price: Not applicable. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 18:28 UTC | EXPONENT INC EXPO · Entity 4154 | SaleCommon Stock | 3,659 | $75.98 | $278,003.87 |
DisclosureSEC source: 0000851520-26-000004 · edgardoc.xml · nonDerivative · entry 2 Pye John · CIK 0001686997 · VP Global Offices & Innovation 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,204 Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 18:28 UTC | EXPONENT INC EXPO · Entity 4154 | SaleCommon Stock | 341 | $75.94 | $25,893.84 |
DisclosureSEC source: 0000851520-26-000004 · edgardoc.xml · nonDerivative · entry 1 Pye John · CIK 0001686997 · VP Global Offices & Innovation 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,863 Read SEC document |
| January 02, 2026 Filed Feb 17, 2026 16:09 UTC | EXPONENT INC EXPO · Entity 4154 | PurchaseCommon Stock | 89 | $66.64 | $5,931.18 |
DisclosureSEC source: 0000851520-26-000010 · edgardoc.xml · nonDerivative · entry 5 Pye John · CIK 0001686997 · VP Global Offices & Innovation 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,581 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
| October 03, 2025 Filed Feb 17, 2026 16:09 UTC | EXPONENT INC EXPO · Entity 4154 | PurchaseCommon Stock | 80 | $63.75 | $5,099.60 |
DisclosureSEC source: 0000851520-26-000010 · edgardoc.xml · nonDerivative · entry 4 Pye John · CIK 0001686997 · VP Global Offices & Innovation 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,492 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
| July 04, 2025 Filed Feb 17, 2026 16:09 UTC | EXPONENT INC EXPO · Entity 4154 | PurchaseCommon Stock | 80 | $73.25 | $5,859.60 |
DisclosureSEC source: 0000851520-26-000010 · edgardoc.xml · nonDerivative · entry 3 Pye John · CIK 0001686997 · VP Global Offices & Innovation 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,412 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
| May 23, 2025 Filed May 23, 2025 20:59 UTC | EXPONENT INC EXPO · Entity 4154 | SaleCommon Stock | 1,658 | $76.32 | $126,530.27 |
DisclosureSEC source: 0000851520-25-000051 · edgardoc.xml · nonDerivative · entry 2 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,204 Read SEC document |
| May 23, 2025 Filed May 23, 2025 20:59 UTC | EXPONENT INC EXPO · Entity 4154 | SaleCommon Stock | 342 | $76.34 | $26,108.28 |
DisclosureSEC source: 0000851520-25-000051 · edgardoc.xml · nonDerivative · entry 1 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,862 Read SEC document |
| April 04, 2025 Filed Feb 17, 2026 16:09 UTC | EXPONENT INC EXPO · Entity 4154 | PurchaseCommon Stock | 67 | $73.21 | $4,904.87 |
DisclosureSEC source: 0000851520-26-000010 · edgardoc.xml · nonDerivative · entry 2 Pye John · CIK 0001686997 · VP Global Offices & Innovation 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,332 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 01:13 UTC | EXPONENT INC EXPO · Entity 4154 | GrantRestricted Stock Units · Derivative | 6,286 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-25-000040 · edgardoc.xml · derivative · entry 1 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,286 Underlying: Common Stock · 6,286 shares Expires 2029-03-14 F1 · derivative.exercise_price: 1-for-1. F2 · price: Not applicable. Read SEC document |
| March 12, 2025 Filed Mar 15, 2025 00:55 UTC | EXPONENT INC EXPO · Entity 4154 | Exercise / conversionRestricted Stock Units · Derivative | 3,438 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-25-000022 · edgardoc.xml · derivative · entry 3 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,438 shares Expires 2025-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the conversion of shares of vested Restricted Stock Units granted on March 12, 2021 into shares of Common Stock on a 1:1 basis. F1 · kind: Reflects the conversion of shares of vested Restricted Stock Units granted on March 12, 2021 into shares of Common Stock on a 1:1 basis. F2 · price: Not applicable. Read SEC document |
| March 12, 2025 Filed Mar 15, 2025 00:55 UTC | EXPONENT INC EXPO · Entity 4154 | Tax withholdingCommon Stock | 866 | $82.33 | $71,297.78 |
DisclosureSEC source: 0000851520-25-000022 · edgardoc.xml · nonDerivative · entry 2 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,204 F3 · kind: Reflects shares of common stock withheld by the Company to satify the tax withholding obligations of the Reporting Person. Read SEC document |
| March 12, 2025 Filed Mar 15, 2025 00:55 UTC | EXPONENT INC EXPO · Entity 4154 | Exercise / conversionCommon Stock | 3,438 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-25-000022 · edgardoc.xml · nonDerivative · entry 1 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects the conversion of shares of vested Restricted Stock Units granted on March 12, 2021 into shares of Common Stock on a 1:1 basis. F2 · price: Not applicable. Read SEC document |
| January 03, 2025 Filed Feb 14, 2025 01:38 UTC | EXPONENT INC EXPO · Entity 4154 | PurchaseCommon Stock | 61 | $84.46 | $5,152.33 |
DisclosureSEC source: 0000851520-25-000008 · edgardoc.xml · nonDerivative · entry 4 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,632 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
| January 03, 2025 Filed Feb 17, 2026 16:09 UTC | EXPONENT INC EXPO · Entity 4154 | PurchaseCommon Stock | 61 | $84.46 | $5,152.33 |
DisclosureSEC source: 0000851520-26-000010 · edgardoc.xml · nonDerivative · entry 1 Pye John · CIK 0001686997 · VP Global Offices & Innovation 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,693 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
| September 27, 2024 Filed Feb 14, 2025 01:38 UTC | EXPONENT INC EXPO · Entity 4154 | PurchaseCommon Stock | 45 | $107.59 | $4,841.44 |
DisclosureSEC source: 0000851520-25-000008 · edgardoc.xml · nonDerivative · entry 3 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,571 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
| July 30, 2024 Filed Jul 31, 2024 15:48 UTC | EXPONENT INC EXPO · Entity 4154 | SaleCommon Stock | 3,956 | $105.00 | $415,380.00 |
DisclosureSEC source: 0000851520-24-000106 · edgardoc.xml · nonDerivative · entry 1 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,422 Read SEC document |
| June 28, 2024 Filed Feb 14, 2025 01:38 UTC | EXPONENT INC EXPO · Entity 4154 | PurchaseCommon Stock | 46 | $90.36 | $4,156.74 |
DisclosureSEC source: 0000851520-25-000008 · edgardoc.xml · nonDerivative · entry 2 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,482 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
| March 29, 2024 Filed Feb 14, 2025 01:38 UTC | EXPONENT INC EXPO · Entity 4154 | PurchaseCommon Stock | 58 | $78.56 | $4,556.22 |
DisclosureSEC source: 0000851520-25-000008 · edgardoc.xml · nonDerivative · entry 1 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,436 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
| March 15, 2024 Filed Mar 20, 2024 00:25 UTC | EXPONENT INC EXPO · Entity 4154 | GrantRestricted Stock Units · Derivative | 6,064 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-24-000049 · edgardoc.xml · derivative · entry 1 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,064 Underlying: Common Stock · 6,064 shares Expires 2028-03-15 F1 · derivative.exercise_price: 1-for-1. F2 · price: Not applicable. Read SEC document |
| March 13, 2024 Filed Mar 16, 2024 00:10 UTC | EXPONENT INC EXPO · Entity 4154 | Exercise / conversionRestricted Stock Units · Derivative | 592 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-24-000031 · edgardoc.xml · derivative · entry 3 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 592 shares Expires 2024-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the conversion of shares of vested Restricted Stock Units granted on March 13, 2020 into shares of Common Stock on a 1:1 basis. F1 · kind: Reflects the conversion of shares of vested Restricted Stock Units granted on March 13, 2020 into shares of Common Stock on a 1:1 basis. F2 · price: Not applicable. Read SEC document |
| March 13, 2024 Filed Mar 16, 2024 00:10 UTC | EXPONENT INC EXPO · Entity 4154 | Tax withholdingCommon Stock | 238 | $78.79 | $18,752.02 |
DisclosureSEC source: 0000851520-24-000031 · edgardoc.xml · nonDerivative · entry 2 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,378 F3 · kind: Reflects shares of common stock withheld by the Company to satify the tax withholding obligations of the Reporting Person. Read SEC document |
| March 13, 2024 Filed Mar 16, 2024 00:10 UTC | EXPONENT INC EXPO · Entity 4154 | Exercise / conversionCommon Stock | 592 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-24-000031 · edgardoc.xml · nonDerivative · entry 1 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,616 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects the conversion of shares of vested Restricted Stock Units granted on March 13, 2020 into shares of Common Stock on a 1:1 basis. F2 · price: Not applicable. Read SEC document |
| December 29, 2023 Filed Feb 12, 2024 19:46 UTC | EXPONENT INC EXPO · Entity 4154 | PurchaseCommon Stock | 42 | $83.64 | $3,512.80 |
DisclosureSEC source: 0000851520-24-000012 · edgardoc.xml · nonDerivative · entry 4 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,024 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
| September 29, 2023 Filed Feb 12, 2024 19:46 UTC | EXPONENT INC EXPO · Entity 4154 | PurchaseCommon Stock | 49 | $81.32 | $3,984.68 |
DisclosureSEC source: 0000851520-24-000012 · edgardoc.xml · nonDerivative · entry 3 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,982 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
| June 30, 2023 Filed Feb 12, 2024 19:46 UTC | EXPONENT INC EXPO · Entity 4154 | PurchaseCommon Stock | 40 | $88.65 | $3,546.16 |
DisclosureSEC source: 0000851520-24-000012 · edgardoc.xml · nonDerivative · entry 2 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,933 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
| March 31, 2023 Filed Feb 12, 2024 19:46 UTC | EXPONENT INC EXPO · Entity 4154 | PurchaseCommon Stock | 38 | $94.71 | $3,598.81 |
DisclosureSEC source: 0000851520-24-000012 · edgardoc.xml · nonDerivative · entry 1 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,893 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 23:12 UTC | EXPONENT INC EXPO · Entity 4154 | Exercise / conversionRestricted Stock Units · Derivative | 702 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-23-000069 · edgardoc.xml · derivative · entry 3 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 702 shares Expires 2023-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: 1-for-1. F1 · kind: Reflects the conversion of shares of vested Restricted Stock Units granted on March 15, 2019 into shares of Common Stock on a 1:1 basis. F2 · price: Not applicable. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 23:12 UTC | EXPONENT INC EXPO · Entity 4154 | Tax withholdingCommon Stock | 177 | $103.41 | $18,303.57 |
DisclosureSEC source: 0000851520-23-000069 · edgardoc.xml · nonDerivative · entry 2 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,855 F3 · kind: Reflects shares of common stock withheld by the Company to satify the tax withholding obligations of the Reporting Person. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 23:12 UTC | EXPONENT INC EXPO · Entity 4154 | Exercise / conversionCommon Stock | 702 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-23-000069 · edgardoc.xml · nonDerivative · entry 1 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,032 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects the conversion of shares of vested Restricted Stock Units granted on March 15, 2019 into shares of Common Stock on a 1:1 basis. F2 · price: Not applicable. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 17:55 UTC | EXPONENT INC EXPO · Entity 4154 | GrantRestricted Stock Units · Derivative | 4,800 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-23-000049 · edgardoc.xml · derivative · entry 1 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,800 Underlying: Common Stock · 4,800 shares Expires 2027-03-10 F1 · derivative.exercise_price: 1-for-1. F2 · price: Not applicable. Read SEC document |
| December 30, 2022 Filed Feb 13, 2023 18:14 UTC | EXPONENT INC EXPO · Entity 4154 | PurchaseCommon Stock | 32 | $94.14 | $3,012.34 |
DisclosureSEC source: 0000851520-23-000014 · edgardoc.xml · nonDerivative · entry 4 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,330 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
| September 30, 2022 Filed Feb 13, 2023 18:14 UTC | EXPONENT INC EXPO · Entity 4154 | PurchaseCommon Stock | 44 | $83.29 | $3,664.61 |
DisclosureSEC source: 0000851520-23-000014 · edgardoc.xml · nonDerivative · entry 3 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,298 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
| July 01, 2022 Filed Feb 13, 2023 18:14 UTC | EXPONENT INC EXPO · Entity 4154 | PurchaseCommon Stock | 36 | $87.01 | $3,132.38 |
DisclosureSEC source: 0000851520-23-000014 · edgardoc.xml · nonDerivative · entry 2 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,254 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
| April 01, 2022 Filed Feb 13, 2023 18:14 UTC | EXPONENT INC EXPO · Entity 4154 | PurchaseCommon Stock | 33 | $102.92 | $3,396.46 |
DisclosureSEC source: 0000851520-23-000014 · edgardoc.xml · nonDerivative · entry 1 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,218 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
| March 11, 2022 Filed Mar 16, 2022 00:41 UTC | EXPONENT INC EXPO · Entity 4154 | GrantRestricted Stock Units · Derivative | 5,934 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-22-000052 · edgardoc.xml · derivative · entry 1 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,934 Underlying: Common Stock · 5,934 shares Expires 2026-03-11 F1 · derivative.exercise_price: 1-for-1. F2 · price: Not applicable. Read SEC document |
| March 09, 2022 Filed Mar 12, 2022 02:38 UTC | EXPONENT INC EXPO · Entity 4154 | Exercise / conversionRestricted Stock Units · Derivative | 1,996 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-22-000031 · edgardoc.xml · derivative · entry 3 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,996 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: 1-for-1. F1 · kind: Reflects the conversion of shares of vested Restricted Stock Units granted on March 9, 2018 into shares of Common Stock on a 1:1 basis. F2 · price: Not applicable. Read SEC document |
| March 09, 2022 Filed Mar 12, 2022 02:38 UTC | EXPONENT INC EXPO · Entity 4154 | Tax withholdingCommon Stock | 535 | $96.44 | $51,595.40 |
DisclosureSEC source: 0000851520-22-000031 · edgardoc.xml · nonDerivative · entry 2 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,185 F3 · kind: Reflects shares of common stock withheld by the Company to satify the tax withholding obligations of the Reporting Person. Read SEC document |
| March 09, 2022 Filed Mar 12, 2022 02:38 UTC | EXPONENT INC EXPO · Entity 4154 | Exercise / conversionCommon Stock | 1,996 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-22-000031 · edgardoc.xml · nonDerivative · entry 1 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,720 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects the conversion of shares of vested Restricted Stock Units granted on March 9, 2018 into shares of Common Stock on a 1:1 basis. F2 · price: Not applicable. Read SEC document |
| December 31, 2021 Filed Feb 12, 2022 01:25 UTC | EXPONENT INC EXPO · Entity 4154 | PurchaseCommon Stock | 26 | $110.89 | $2,883.23 |
DisclosureSEC source: 0000851520-22-000009 · edgardoc.xml · nonDerivative · entry 4 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,724 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
| October 01, 2021 Filed Feb 12, 2022 01:25 UTC | EXPONENT INC EXPO · Entity 4154 | PurchaseCommon Stock | 31 | $108.83 | $3,373.79 |
DisclosureSEC source: 0000851520-22-000009 · edgardoc.xml · nonDerivative · entry 3 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,698 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
| July 02, 2021 Filed Feb 12, 2022 01:25 UTC | EXPONENT INC EXPO · Entity 4154 | PurchaseCommon Stock | 33 | $86.23 | $2,845.64 |
DisclosureSEC source: 0000851520-22-000009 · edgardoc.xml · nonDerivative · entry 2 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,667 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
| April 02, 2021 Filed Feb 12, 2022 01:25 UTC | EXPONENT INC EXPO · Entity 4154 | PurchaseCommon Stock | 35 | $93.90 | $3,286.43 |
DisclosureSEC source: 0000851520-22-000009 · edgardoc.xml · nonDerivative · entry 1 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,634 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 19:53 UTC | EXPONENT INC EXPO · Entity 4154 | GrantRestricted Stock Units · Derivative | 3,438 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-21-000052 · edgardoc.xml · derivative · entry 1 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,438 Underlying: Common Stock · 3,438 shares Expires 2025-03-12 F1 · derivative.exercise_price: 1-for-1. F2 · price: Not applicable. Read SEC document |
| March 10, 2021 Filed Mar 15, 2021 17:43 UTC | EXPONENT INC EXPO · Entity 4154 | Exercise / conversionRestricted Stock Units · Derivative | 3,408 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-21-000029 · edgardoc.xml · derivative · entry 3 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,408 shares Expires 2021-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: 1-for-1. F1 · kind: Reflects the conversion of shares of vested Restricted Stock Units granted on March 10, 2017 into shares of Common Stock on a 1:1 basis. F2 · price: Not applicable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.